Phillip E. Korenblat

Lebrikizumab Treatment in Adults with Asthma

Jonathan Corren, Robert F. Lemanske, Nicola A. Hanania et al. · New England Journal of Medicine · 2011 · 1.5K citations

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 463 citations

Asthma, Rheumatology, Allergy +10

The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease

Stephen I. Rennard, Charles Fogarty, Steven G. Kelsen et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 426 citations

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 374 citations · Full text

Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids

Michael Noonan, Phillip E. Korenblat, Sofia Mosesova et al. · Journal of Allergy and Clinical Immunology · 2013 · 168 citations

Asthma, Allergy, Allergy Medicine +8